<DOC>
	<DOCNO>NCT01756651</DOCNO>
	<brief_summary>The purpose study assess safety efficacy intranasally-administrated fentanyl pectin spray ( Lazanda® ) give decrease pain cystoscopy ( passage telescopic instrument bladder purpose diagnose cause blood urine , urinary complaint problem urinary bladder ) . The current standard practice use Lidocaine jelly ( local anesthetic ) give urethra lubricate decrease local pain . In study , additional medicine ( Lazanda® ) use reduce pain occurs procedure .</brief_summary>
	<brief_title>Intranasal Fentanyl Management Pain Associated With Cystoscopic Procedures</brief_title>
	<detailed_description>In prospective study , twenty subject enrol . The first ten receive dose 100mcg pectin fentanyl nasal spray ( Lazanda® ) . The second ten receive dose 200mcg pectin fentanyl nasal spray ( Lazanda® ) 100mcg well tolerate first ten . In case , Lidocaine jelly use local anesthetic urethra .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Pectin</mesh_term>
	<criteria>1 . Male adult patient schedule cystoscopy ; additional procedure ( e.g . ureteral stent placement , stent exchange , bladder biopsy , retrograde pyelogram ) may include . 1 . History analgesic abuse opioid tolerance 2 . Allergy fentanyl component Lazanda® 3 . Acute/chronic nasal problem rhinitis sinusitis 4 . Acute bronchial asthma / upper airway obstruction 5 . Presence bradycardia history seizures 6 . Concomitant use drug inhibit cytochrome P450 isoenzyme 3A4 ( e.g. , ritonavir , ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , nefazodone , amprenavir , aprepitant , diltiazem , erythromycin , fluconazole , fosamprenavir , monoamine oxidase inhibitor verapamil ) exposure drug 30 day prior placement study . 7 . Concomitant use vasoconstrictive nasal decongestant ( e.g. , oxymetazoline , phenylephrine , xylometazoline ) 8 . Numeric Rating Scale ( NRS ) pain score 0 baseline 9 . Any situation condition , investigator 's opinion , put subject significant risk , could confound study result .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Intranasal fentanyl</keyword>
	<keyword>Cystoscopy</keyword>
</DOC>